SCHEMBL12495652

SCHEMBL12495652

CNC(=O)c1ncnn1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 2/20 0.42
MAPK14 Q16539 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
CLK1 P49759 1/20 0.33
EGLN2 Q96KS0 1/20 0.33
PDE10A Q9Y233 2/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
KDM4E B2RXH2 1/20 0.33
KDM4A O75164 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ABL1 P00519 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
CDH1 P12830 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8996043 0.79 KDM4E (0.42) SMN1; SMN2EGLN2KDM4EALDH1A1TP53
SCHEMBL8996016 0.79 MAP4K4 (0.38) MAPK14PDE10AKDM4ELMNAMAPT
SCHEMBL12410718 0.77 MAPK14 (0.38) BAZ2BMAPK14EGLN2NPC1RAB9A
SCHEMBL8995994 0.76 MEN1 (0.35) SMN1; SMN2EGLN2PDE10ANPC1RAB9A
SCHEMBL8950240 0.76 PIK3CA (0.38) BAZ2BEGLN2PDE10ABRD4
SCHEMBL8996040 0.75 MAOB (0.42) RAB9AKDM4ELMNATSHRBLM
SCHEMBL12496155 0.75
SCHEMBL25458163 0.72 KDM4E (0.33) NPC1RAB9AKDM4EKDM4AALDH1A1
SCHEMBL15139623 0.72 KMT2A (0.33) SMN1; SMN2PDE10ANPC1RAB9AKDM4E
SCHEMBL510655 0.71 GAA (0.33) SMN1; SMN2KDM4EALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130289013-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SUNOVION PHARMACEUTICALS INC. 2013-10-31 US disclosed
US-8497278-B2 Imidazo[1,2-a]pyridine compounds SUNOVION PHARMACEUTICALS INC. (US) 2013-07-30 US disclosed
US-20110166146-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SUNOVION PHARMACEUTICALS INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166146-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS PAICS, ITPA, DPYD BAZ2B 3047/4885MAPK14 4355/4885SMN1; SMN2 593/4885
US-20130289013-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS PAICS, ITPA, DPYD BAZ2B 3047/4885MAPK14 4355/4885SMN1; SMN2 593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.